Cargando…
IGF-I activates caspases 3/7, 8 and 9 but does not induce cell death in colorectal cancer cells
BACKGROUND: Colorectal cancer is the third most common cancer in the western world. Chemotherapy is often ineffective to treat the advanced colorectal cancers due to the chemo-resistance. A major contributor to chemo-resistance is tumour-derived inhibition or avoidance of apoptosis. Insulin-like gro...
Autores principales: | Yang, Shi Yu, Bolvin, Capucine, Sales, Kevin M, Fuller, Barry, Seifalian, Alexander M, Winslet, Marc C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698923/ https://www.ncbi.nlm.nih.gov/pubmed/19460165 http://dx.doi.org/10.1186/1471-2407-9-158 |
Ejemplares similares
-
Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide
por: Yang, Shi Yu, et al.
Publicado: (2008) -
Does Doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
por: Sagar, Jayesh, et al.
Publicado: (2009) -
Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells
por: Ganesh, Radhakrishnan, et al.
Publicado: (2012) -
Role of stem cells in cancer therapy and cancer stem cells: a review
por: Sagar, Jayesh, et al.
Publicado: (2007) -
In vitro small intestinal epithelial cell growth on a nanocomposite polycaprolactone scaffold
por: Gupta, Ashish, et al.
Publicado: (2009)